Accepting premature deaths from smoking.

1) Smoking cessation 2) Replacement of the pharmacologic (pleasurable) sensations of nicotine in cigarette products with non-cigarette products that can be viewed as providing either medicinal nicotine or analogue chemicals with similar function 3) Reduction in toxic components of cigarette smoke immediately to levels that are suggested by current science as ‘‘acceptable’’ based on existing dose–response data for cumulative lifetime exposure. (This is a central part of the theme of the California Environmental Protection Agency’s requirements— that is, that there are levels of chemicals for which the risk is not more than ‘‘background’’.) 4) Partial reductions in some toxic components over time to eventually lead to products with reduced premature death rates